09.12.2019 at 18:31:34    

 Welcome, Guest. Please Login.
Pages: 1
1999 (Read 4603 times)
sharip
Group Leader
***




Posts: 37
Gender: male
1999
20.03.2007 at 12:39:50
 

1.      Pumpens P., Grens E., Hepatitis B core paricles as a universal display model: a structure-function basis for development. FEBS Latters 442, 1-6, 442,1999.
2.      Preikschat P., Borisova G., Borschukova O., Dislers A., Mezule G., Grens E., Krüger D.H., Pumpens P.,  Meisel H. Expression, assembly competence and antigenic properties of hepatitis B virus core gene deletion variants from infected liver cells. J Gen Virol. 80, 1777-1788 ,1999.  
3.      Lachmann, S., Meisel H., Muselmann C., Koletzki D., Gelderblom H.R., Borisova G., Krüger D.H., Pumpens P., Ulrich R. Characterization of potential insertion sites in the core antigen of hepatitis B virus by the use of a short-sized model epitope. Intervirology, 42, 51-56, 1999.  
4.      Borisova G., Borschukova O., Skrastina D., Dislers A., Ose V., Pumpens P. Grens E. Behavior of a short preS1 epitope on the surface of hepatitis B core particles. Biol. Chem., 380, 315-324, 1999
5.      Klovins J., Van Duin J., A long-range pseudoknot in Qb is essential for replication. J.Mol.Biol., 294, 875-884, 1999.
6.      Ulrich R., Koletzki D., Lachmann S., Lundkvist A., Zankl A., Kazaks A., Kurth A., Gelderblom H.R., Borisova G., Meisel H., Kruger D.H., New chimeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: immmunogenicity and protection against virus challange, J.of  Biotechnology 73, 141.-153., 1999.
7.      Baumanis V., Jansone I., Marga O., Broka I., Pancuka t., Mandrika I., Evaluation of two amplification technologies for the detection of Mycobacterium tuberculosis. Biochemie, Vol. 81, Nr.6, 396, 1999.
8.      Chuvpilo S., Zimmer M., Kerstan A., Glockner J., Avots A., Escher C., Fischer C., Inashkina I., Jankevics E., Berberich-siebelt F., Schmitt E. Serfling E., Alternative polyadenylation events contribute to the induction of NF-Atc in effector T cells. Immunity, Vol.10, 261-269, 1999.
9.      Bruvere R., Pilmane M., Feldmane G., Volrate A., Loza V., Kinetics of cell-derived double-standed ribonucleic acids during differentiation. Analytical Cellular Pathology, Vol. 18, Nr.1, 16, 1999.
10.      Mazarevica G., Leice A., Auce Z., Freivalds T., Bruvere R., Morpho-functional analysis of erythroid system of the Chernobyl clean-up workers from Latvia. Analytical cellular Pathology, Vol. 18, Nr.1., 39, 1999.
11.      Bruvere R., Leice A., Bruveris U., Evaluatin of Chernobyl acciedent health effects by hemathological and Clinical biochemistry tests. Epidemilogy, vol. 10, Nr. 4, 518,1999.
12.      Heisele O., Engele L., Ferdats A., Bruvere R., Desjatnikova I., Melanoma associated antigens as additional markers of tumor growth. J. Tumor Oncology, Vol. 14, Nr.2, 62063, 1999.
13.      Kristufek V., Fischer J., Buhrmann J., Zeltins A., Schrempf H., In situ monitoring of chitin degradation by Streptomyces lividans  pCHIO12 within Enchytraeus crypticus (Oligochaeta) feeding on Aspergillus proliferans. FEMS Microbiol. Ecology, Vol. 28, 41-48, 1999.  
14.      Muiznieks I., Rostoks N., Schmitt R. Effective regulation of transcription of the bacterial raf operon by two Raf repressor dimers and CAP protein that bend DNA in opposite directions. Biol. Chem., 380, 19 –29, 1999.
15.      Chuvpilo S., Kerstan A., Glokner J., Avots A., Escher C., Fischer C., Innashkina I., Jankevics E., Siebelt F., Serfling E. Coordinated synthesis and nuclear translocation of NF-ATc isoforms during T cell  activation (abstract0. Immunobiology, Vol. 197, 184-185, 1999.    
16.      Chuvpilo S., Kerstan A., Glokner J., Avots A., Escher C., Fischer C., Innashkina I., Jankevics E., Serfling E., Berberich-Siebelt F., Hlubek F.,Brabletz T. Multiple NFATc isoforms  with individual transcripptional properties are synthesized in T Lymphocytes. Immunology 162 (12), 7294-7301, 1999.  
17.      Tihomirova L., Csokay B., Stengrevics A., Sinicka O., Kamerade R.,  Hereditary  Brest cancer in Latvia: Mutation Analysis of the BRCA 1 gene. Disease Markers.15, 97,1999.
18.      Zhilevica A., Bondare D., Strozha I., Cimanis A., Feldmane G., Grante H., Treimane R., Linē A.. Interferon alpha therapy in chronic myeloid leukemia and detection of bcr/abl transcripts. Proc.Latvian Acad.Sci., Section B, vol.52, No.3/4, 102-107,1999.
19.      Petuhov V.I., Strozda I., Zhilevich A.Bondare D., Line A., Jankevics E., Tsimanis A., Treimane R., Krumina A. Effectiveness of alfa-interferon therapy and bcr-abl transcripts in patients with chronic myeloid leukemia (CML). Gematol. Transfuziol., 44(1):3-6, 1999, [in Russian],  
20.      Petuhov V.I., Bondare D., Stroza I., Jankevics E., Line A., Zhilevica a., Kovaleva Z., Teilane I. Three family cases of CML expressing hybrid BCR-ABL gene. Gematol.Transfuziol., 44(3):46-47,1999, [in Russian],
21.      Zhilevich A., Bondare D., Stroza I., Petuhov V., Jankevics E., Line A. Correlation of BCR-ABL  expression with prognosis of CML. Latvijas Ārsts,(1):18-22,1999, [in Latvian].
22.      Dumpis U., Crook D., Oksi J. Tick-borne encephalitis. Clinical Inefectious diseases 141-147,1999.  
Back to top
 
 
View Profile   IP Logged
Pages: 1